Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05944549 · ClinicalTrials.gov registry record · NA
Financial Coaching and Lifestyle Intervention for Diabetes Prevention in Low-income Families
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
NCT05944549: Completed NA study, sponsored by The University of Texas Health Science Center, Houston.
NCT05944549 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 58 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05944549, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effect on weight and metabolic outcomes of an enhanced intervention, comprised of evidence-based financial coaching plus a lifestyle intervention vs. the lifestyle intervention alone
Primary Outcome
Average of the 2 weights will be calculated
Interventions
- BEHAVIORAL Brighter Bites
- BEHAVIORAL Financial coaching using TrustPlus
- BEHAVIORAL Noom
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2023-05-12 |
| Est. Completion | 2025-02-15 |
| Phase | NA |
What the finished NCT05944549 record still lists
NCT05944549 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Brighter Bites is the first listed.
NCT05944549 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05944549 about?
NCT05944549 is a clinical study titled "Financial Coaching and Lifestyle Intervention for Diabetes Prevention in Low-income Families". The purpose of this study is to compare the effect on weight and metabolic outcomes of an enhanced intervention, comprised of evidence-based financial coaching plus a lifestyle intervention vs. the lifestyle intervention alone
What is the current status of trial NCT05944549?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2023-05-12. Estimated completion is 2025-02-15.
What interventions are being tested in trial NCT05944549?
The interventions under investigation include: Brighter Bites (BEHAVIORAL), Financial coaching using TrustPlus (BEHAVIORAL), Noom (BEHAVIORAL).
Who is sponsoring clinical trial NCT05944549?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05944549's enrollment target sits among peer trials
58 1256th of 2000 higher than 740 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI